MwanzoDC4 • ETR
add
DexCom Inc
Bei iliyotangulia
€ 72.28
Bei za siku
€ 74.48 - € 75.31
Bei za mwaka
€ 51.62 - € 121.80
Thamani ya kampuni katika soko
33.46B USD
Wastani wa hisa zilizouzwa
388.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.04B | 12.49% |
Matumizi ya uendeshaji wa biashara | 455.30M | -1.19% |
Mapato halisi | 105.40M | -28.01% |
Kiwango cha faida halisi | 10.17 | -36.04% |
Mapato kwa kila hisa | 0.32 | 0.00% |
EBITDA | 193.70M | 26.11% |
Asilimia ya kodi ya mapato | 31.69% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.70B | -6.75% |
Jumla ya mali | 6.75B | 4.16% |
Jumla ya dhima | 4.49B | 5.90% |
Jumla ya hisa | 2.27B | — |
hisa zilizosalia | 392.11M | — |
Uwiano wa bei na thamani | 12.51 | — |
Faida inayotokana na mali | 5.05% | — |
Faida inayotokana mtaji | 7.00% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 105.40M | -28.01% |
Pesa kutokana na shughuli | 183.80M | -12.14% |
Pesa kutokana na uwekezaji | 100.20M | 33.96% |
Pesa kutokana na ufadhili | 12.50M | 165.96% |
Mabadiliko halisi ya pesa taslimu | 298.80M | 4.88% |
Mtiririko huru wa pesa | 67.92M | -39.14% |
Kuhusu
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Makao Makuu
Tovuti
Wafanyakazi
10,250
